Comparison of reversal of rat pulmonary fibrosis of nintedanib, pirfenidone, and human umbilical mesenchymal stem cells from Wharton's jelly.

Stem Cell Res Ther · 2020 · PMC7702727 · PMID 33256831

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The expression level of α-SMA in the BLM + Nintedanib and BLM + Pirfenidone groups showed a decreasing trend, but not a significant amelioration as compared with that in the BLM group (Fig. 6 a–c).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.